CPRX Dividend: Catalyst Pharmaceuticals Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	578	491	398	214	140	119
Revenue Growth (YoY)	26%	23%	86%	53%	18%	17%
Cost of Revenue	83	68	51	34	21	17
Gross Profit	495	422	346	179	118	102
Selling, General & Admin	184	177	133	58	49	44
Research & Development	14	12	93	19	16	16
Operating Expenses	236	227	259	78	66	60
Other Non Operating Income (Expenses)	26	21	7	2	0	0
Pretax Income	285	216	94	104	52	41
Income Tax Expense	67	52	23	21	13	-33
Net Income	217	163	71	83	39	75
Net Income Growth	52%	130%	-14%	112.99%	-48%	142%
Shares Outstanding (Diluted)	127.09	124.94	113.75	111.4	107.8	106.2
Shares Change (YoY)	2%	10%	2%	3%	2%	0%
EPS (Diluted)	1.71	1.31	0.62	0.75	0.37	0.71
EPS Growth	50%	109%	-16%	103%	-48%	137%
Free Cash Flow	234	239	143	116	59	45
Free Cash Flow Per Share	1.84	1.91	1.25	1.04	0.54	0.42
Gross Margin	85.64%	85.94%	86.93%	83.64%	84.28%	85.71%
Operating Margin	44.63%	39.71%	21.6%	47.19%	37.14%	34.45%
Profit Margin	37.54%	33.19%	17.83%	38.78%	27.85%	63.02%
Free Cash Flow Margin	40.48%	48.67%	35.92%	54.2%	42.14%	37.81%
EBITDA	295	232	118	102	52	41
EBITDA Margin	51.03%	47.25%	29.64%	47.66%	37.14%	34.45%
D&A For EBITDA	37	37	32	1	0	0
EBIT	258	195	86	101	52	41
EBIT Margin	44.63%	39.71%	21.6%	47.19%	37.14%	34.45%
Effective Tax Rate	23.5%	24.07%	24.46%	20.19%	25%	-80.48%

Catalyst Pharmaceuticals Inc (CPRX) Price